Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL523906

O=C(O)C(O)C(O)C(=O)O.O=C(c1ccc(Cl)nc1)N1CCCN(C2CCC2)CC1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 17/20 0.63
KCNH2 Q12809 4/20 0.63
L3MBTL3 Q96JM7 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL523887 0.92 HRH3 (0.68) HRH3KCNH2L3MBTL3L3MBTL1
Hydrochloric Acid SCHEMBL524379 0.91 HRH3 (0.67) HRH3KCNH2L3MBTL3L3MBTL1
SCHEMBL24185708 0.84 RAB9A (0.60) HRH3KCNH2L3MBTL3L3MBTL1
SCHEMBL3767528 0.80 HRH3 (0.53) HRH3KCNH2L3MBTL3L3MBTL1
SCHEMBL16253091 0.79 L3MBTL3 (0.69) HRH3KCNH2L3MBTL3L3MBTL1
SCHEMBL423224 0.79 RAB9A (0.65) L3MBTL1
SCHEMBL10138882 0.78 HRH3 (0.64) HRH3KCNH2L3MBTL3L3MBTL1
SCHEMBL19556668 0.78 HRH3 (0.64) HRH3KCNH2L3MBTL3L3MBTL1
SCHEMBL18600275 0.78 HRH3 (0.64) HRH3KCNH2L3MBTL3L3MBTL1
SCHEMBL21074361 0.78 HRH3 (0.51) HRH3KCNH2L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809547-B2 Process for the preparation of histamine H3 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2017-11-07 US disclosed
US-20170057919-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-03-02 US disclosed
US-9518021-B2 Process for the preparation of histamine H3 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2016-12-13 US disclosed
US-20140343279-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-11-20 US disclosed
US-8748596-B2 Process for the preparation of histamine H3 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2014-06-10 US disclosed
US-20120029189-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170057919-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS HRH3, HRH4, HRH1 HRH3 1/4885KCNH2 884/4885L3MBTL3 4419/4885
US-20140343279-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS HRH3, HRH4, HRH1 HRH3 1/4885KCNH2 884/4885L3MBTL3 4419/4885
US-20120029189-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS HRH3, HRH4, HRH1 HRH3 1/4885KCNH2 884/4885L3MBTL3 4419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.